Subcutaneous
Subcutaneous — Pertaining to the tissue layer beneath the skin. A common route of administration for peptides in in vivo research studies.
What Does Subcutaneous Mean?
Subcutaneous (SC or SQ) refers to the tissue layer between the skin (dermis) and the muscle (fascia), and subcutaneous injection is the most common route of administration for peptide compounds in research protocols. The subcutaneous space provides a depot from which peptides are absorbed gradually into the bloodstream through capillary networks.
Why SC for Peptides
- Slow absorption: Creates a depot effect, producing sustained plasma levels compared to IV bolus
- Ease of administration: Simple technique requiring minimal training and no vascular access
- Self-administration: Practical for repeated dosing protocols in animal studies
- Reduced first-pass: Bypasses gastrointestinal degradation and hepatic first-pass metabolism
PK Considerations
SC absorption rate depends on peptide molecular weight, formulation viscosity, injection volume, and local blood flow. Small peptides (< 5 kDa) are absorbed within 30-60 minutes. Larger peptides and depot formulations may take hours to days. Bioavailability via SC route is typically 50-80% for most research peptides, significantly higher than oral administration.
Frequently Asked Questions
What is Subcutaneous?
Pertaining to the tissue layer beneath the skin. A common route of administration for peptides in in vivo research studies.
Why is Subcutaneous important in peptide research?
Subcutaneous is a fundamental concept in research as it relates to peptide science. It directly influences experimental design, compound characterization, and the reliability of research outcomes across biochemistry and molecular biology disciplines.